Upgrades
- According to Wolfe Research, the prior rating for CVR Energy Inc CVI was changed from Peer Perform to Outperform. CVR Energy earned $0.24 in the third quarter, compared to $0.57 in the year-ago quarter. The current stock performance of CVR Energy shows a 52-week-high of $27.02 and a 52-week-low of $11.22. Moreover, at the end of the last trading period, the closing price was at $18.94.
- According to UBS, the prior rating for Honeywell International Inc HON was changed from Neutral to Buy. In the third quarter, Honeywell International showed an EPS of $2.02, compared to $1.56 from the year-ago quarter. The current stock performance of Honeywell International shows a 52-week-high of $236.86 and a 52-week-low of $194.55. Moreover, at the end of the last trading period, the closing price was at $210.82.
- Truist Securities upgraded the previous rating for Spirit AeroSystems Holdings Inc SPR from Hold to Buy. In the third quarter, Spirit AeroSystems Hldgs showed an EPS of $1.13, compared to $1.34 from the year-ago quarter. At the moment, the stock has a 52-week-high of $53.63 and a 52-week-low of $32.93. Spirit AeroSystems Hldgs closed at $45.83 at the end of the last trading period.
- For Heico Corp HEI, Truist Securities upgraded the previous rating of Hold to Buy. For the fourth quarter, Heico had an EPS of $0.62, compared to year-ago quarter EPS of $0.45. The current stock performance of Heico shows a 52-week-high of $151.60 and a 52-week-low of $115.57. Moreover, at the end of the last trading period, the closing price was at $146.45.
- For Hexcel Corp HXL, Truist Securities upgraded the previous rating of Hold to Buy. Hexcel earned $0.13 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $64.99 and a 52-week-low of $42.91. At the end of the last trading period, Hexcel closed at $54.43.
- For TransDigm Group Inc TDG, Truist Securities upgraded the previous rating of Hold to Buy. For the fourth quarter, TransDigm Gr had an EPS of $4.25, compared to year-ago quarter EPS of $2.89. The current stock performance of TransDigm Gr shows a 52-week-high of $688.03 and a 52-week-low of $517.37. Moreover, at the end of the last trading period, the closing price was at $644.76.
- According to Oppenheimer, the prior rating for Chipotle Mexican Grill Inc CMG was changed from Perform to Outperform. For the third quarter, Chipotle Mexican Grill had an EPS of $7.02, compared to year-ago quarter EPS of $3.76. The stock has a 52-week-high of $1958.55 and a 52-week-low of $1256.27. At the end of the last trading period, Chipotle Mexican Grill closed at $1620.97.
- For Dover Corp DOV, Oppenheimer upgraded the previous rating of Perform to Outperform. Dover earned $1.98 in the third quarter, compared to $1.60 in the year-ago quarter. The current stock performance of Dover shows a 52-week-high of $183.72 and a 52-week-low of $115.88. Moreover, at the end of the last trading period, the closing price was at $181.47.
- Odeon Capital upgraded the previous rating for KeyCorp KEY from Hold to Buy. KeyCorp earned $0.66 in the third quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.03 and a 52-week-low of $16.69. KeyCorp closed at $25.93 at the end of the last trading period.
- For Winnebago Industries Inc WGO, CL King upgraded the previous rating of Neutral to Strong Buy. Winnebago Industries earned $3.51 in the first quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $87.53 and a 52-week-low of $60.80. Winnebago Industries closed at $76.45 at the end of the last trading period.
- According to Guggenheim, the prior rating for DexCom Inc DXCM was changed from Neutral to Buy. In the third quarter, DexCom showed an EPS of $0.89, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $659.45 and a 52-week-low of $318.45. At the end of the last trading period, DexCom closed at $483.00.
- According to B of A Securities, the prior rating for Illumina Inc ILMN was changed from Underperform to Neutral. In the third quarter, Illumina showed an EPS of $1.45, compared to $1.02 from the year-ago quarter. The current stock performance of Illumina shows a 52-week-high of $555.77 and a 52-week-low of $341.03. Moreover, at the end of the last trading period, the closing price was at $378.93.
- B of A Securities upgraded the previous rating for Delta Air Lines Inc DAL from Neutral to Buy. Delta Air Lines earned $0.30 in the third quarter, compared to $3.30 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.28 and a 52-week-low of $33.40. Delta Air Lines closed at $40.11 at the end of the last trading period.
- RBC Capital upgraded the previous rating for Box Inc BOX from Underperform to Sector Perform. Box earned $0.22 in the third quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $28.13 and a 52-week-low of $16.85. At the end of the last trading period, Box closed at $25.40.
- According to Credit Suisse, the prior rating for McKesson Corp MCK was changed from Neutral to Outperform. For the second quarter, McKesson had an EPS of $6.15, compared to year-ago quarter EPS of $4.80. The stock has a 52-week-high of $251.04 and a 52-week-low of $169.34. At the end of the last trading period, McKesson closed at $244.61.
- For Henry Schein Inc HSIC, Credit Suisse upgraded the previous rating of Neutral to Outperform. In the third quarter, Henry Schein showed an EPS of $1.10, compared to $1.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $83.45 and a 52-week-low of $60.70. Henry Schein closed at $77.86 at the end of the last trading period.
- Exane BNP Paribas upgraded the previous rating for BP PLC BP from Neutral to Outperform. For the third quarter, BP had an EPS of $0.99, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $30.29 and a 52-week-low of $20.43. At the end of the last trading period, BP closed at $28.81.
- Exane BNP Paribas upgraded the previous rating for Deutsche Bank AG DB from Underperform to Neutral. For the third quarter, Deutsche Bank had an EPS of $0.17, compared to year-ago quarter EPS of $0.15. The current stock performance of Deutsche Bank shows a 52-week-high of $15.34 and a 52-week-low of $10.08. Moreover, at the end of the last trading period, the closing price was at $13.84.
- According to Exane BNP Paribas, the prior rating for UBS Group AG UBS was changed from Neutral to Outperform. For the third quarter, UBS Group had an EPS of $0.63, compared to year-ago quarter EPS of $0.56. At the moment, the stock has a 52-week-high of $18.74 and a 52-week-low of $14.32. UBS Group closed at $18.39 at the end of the last trading period.
- Jefferies upgraded the previous rating for CarGurus Inc CARG from Hold to Buy. CarGurus earned $0.38 in the third quarter, compared to $0.37 in the year-ago quarter. The current stock performance of CarGurus shows a 52-week-high of $39.77 and a 52-week-low of $22.63. Moreover, at the end of the last trading period, the closing price was at $32.54.
- B of A Securities upgraded the previous rating for Discovery Inc DISCA from Neutral to Buy. For the third quarter, Discovery had an EPS of $0.24, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $78.14 and a 52-week-low of $21.66. At the end of the last trading period, Discovery closed at $25.72.
- For AT&T Inc T, Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. For the third quarter, AT&T had an EPS of $0.87, compared to year-ago quarter EPS of $0.76. The current stock performance of AT&T shows a 52-week-high of $33.88 and a 52-week-low of $22.02. Moreover, at the end of the last trading period, the closing price was at $26.11.
- According to Jefferies, the prior rating for Outbrain Inc OB was changed from Hold to Buy. The stock has a 52-week-high of $20.99 and a 52-week-low of $13.00. At the end of the last trading period, Outbrain closed at $14.17.
See all analyst ratings upgrades.
Downgrades
- UBS downgraded the previous rating for AutoZone Inc AZO from Buy to Neutral. In the first quarter, AutoZone showed an EPS of $25.69, compared to $18.61 from the year-ago quarter. The current stock performance of AutoZone shows a 52-week-high of $2110.00 and a 52-week-low of $1111.71. Moreover, at the end of the last trading period, the closing price was at $2062.49.
- According to Stephens & Co., the prior rating for Veeva Systems Inc VEEV was changed from Overweight to Equal-Weight. In the third quarter, Veeva Systems showed an EPS of $0.97, compared to $0.78 from the year-ago quarter. The stock has a 52-week-high of $343.96 and a 52-week-low of $235.74. At the end of the last trading period, Veeva Systems closed at $241.67.
- According to Scotiabank, the prior rating for Fortis Inc FTS was changed from Sector Outperform to Sector Perform. In the third quarter, Fortis showed an EPS of $0.51, compared to $0.49 from the year-ago quarter. The stock has a 52-week-high of $48.39 and a 52-week-low of $38.49. At the end of the last trading period, Fortis closed at $46.72.
- For Texas Instruments Inc TXN, Citigroup downgraded the previous rating of Buy to Neutral. For the third quarter, Texas Instruments had an EPS of $2.07, compared to year-ago quarter EPS of $1.45. At the moment, the stock has a 52-week-high of $202.26 and a 52-week-low of $161.67. Texas Instruments closed at $186.76 at the end of the last trading period.
- For Starbucks Corp SBUX, Oppenheimer downgraded the previous rating of Outperform to Perform. Starbucks earned $1.00 in the fourth quarter, compared to $0.51 in the year-ago quarter. The current stock performance of Starbucks shows a 52-week-high of $126.32 and a 52-week-low of $95.92. Moreover, at the end of the last trading period, the closing price was at $111.14.
- Mizuho downgraded the previous rating for Visa Inc V from Buy to Neutral. For the fourth quarter, Visa had an EPS of $1.62, compared to year-ago quarter EPS of $1.12. At the moment, the stock has a 52-week-high of $252.67 and a 52-week-low of $190.10. Visa closed at $219.75 at the end of the last trading period.
- According to B of A Securities, the prior rating for Allegiant Travel Co ALGT was changed from Buy to Neutral. For the third quarter, Allegiant Travel had an EPS of $0.66, compared to year-ago quarter EPS of $4.28. The stock has a 52-week-high of $271.29 and a 52-week-low of $163.59. At the end of the last trading period, Allegiant Travel closed at $177.60.
- For Equinix Inc EQIX, BMO Capital downgraded the previous rating of Outperform to Market Perform. In the third quarter, Equinix showed an EPS of $6.94, compared to $6.48 from the year-ago quarter. The current stock performance of Equinix shows a 52-week-high of $885.26 and a 52-week-low of $586.73. Moreover, at the end of the last trading period, the closing price was at $775.08.
- For Starbucks Corp SBUX, RBC Capital downgraded the previous rating of Outperform to Sector Perform. For the fourth quarter, Starbucks had an EPS of $1.00, compared to year-ago quarter EPS of $0.51. The current stock performance of Starbucks shows a 52-week-high of $126.32 and a 52-week-low of $95.92. Moreover, at the end of the last trading period, the closing price was at $111.14.
- Jefferies downgraded the previous rating for Lyft Inc LYFT from Buy to Hold. Lyft earned $0.05 in the third quarter, compared to $0.89 in the year-ago quarter. The current stock performance of Lyft shows a 52-week-high of $68.28 and a 52-week-low of $36.25. Moreover, at the end of the last trading period, the closing price was at $43.60.
- According to UBS, the prior rating for Kohl's Corp KSS was changed from Neutral to Sell. For the third quarter, Kohl's had an EPS of $1.65, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $64.80 and a 52-week-low of $40.03. Kohl's closed at $49.02 at the end of the last trading period.
- For Chewy Inc CHWY, Piper Sandler downgraded the previous rating of Overweight to Neutral. In the third quarter, Chewy showed an EPS of $0.08, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $120.00 and a 52-week-low of $50.05. Chewy closed at $52.89 at the end of the last trading period.
- According to Morgan Stanley, the prior rating for Teleflex Inc TFX was changed from Overweight to Equal-Weight. In the third quarter, Teleflex showed an EPS of $3.51, compared to $2.77 from the year-ago quarter. At the moment, the stock has a 52-week-high of $449.38 and a 52-week-low of $289.00. Teleflex closed at $326.86 at the end of the last trading period.
- According to Morgan Stanley, the prior rating for Stryker Corp SYK was changed from Overweight to Equal-Weight. Stryker earned $2.20 in the third quarter, compared to $2.14 in the year-ago quarter. The current stock performance of Stryker shows a 52-week-high of $281.16 and a 52-week-low of $220.90. Moreover, at the end of the last trading period, the closing price was at $271.50.
- For Nevro Corp NVRO, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the third quarter, Nevro had an EPS of $0.87, compared to year-ago quarter EPS of $0.29. The current stock performance of Nevro shows a 52-week-high of $184.85 and a 52-week-low of $79.44. Moreover, at the end of the last trading period, the closing price was at $83.73.
- For Medtronic PLC MDT, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Medtronic earned $1.32 in the second quarter, compared to $1.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $135.89 and a 52-week-low of $98.38. Medtronic closed at $104.97 at the end of the last trading period.
- Morgan Stanley downgraded the previous rating for Zimmer Biomet Holdings Inc ZBH from Overweight to Equal-Weight. In the third quarter, Zimmer Biomet Holdings showed an EPS of $1.81, compared to $1.81 from the year-ago quarter. The stock has a 52-week-high of $180.36 and a 52-week-low of $116.60. At the end of the last trading period, Zimmer Biomet Holdings closed at $128.93.
- UBS downgraded the previous rating for Abercrombie & Fitch Co ANF from Buy to Neutral. For the third quarter, Abercrombie & Fitch had an EPS of $0.86, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $48.97 and a 52-week-low of $21.01. Abercrombie & Fitch closed at $34.31 at the end of the last trading period.
- JP Morgan downgraded the previous rating for DTE Energy Co DTE from Overweight to Neutral. DTE Energy earned $1.72 in the third quarter, compared to $2.61 in the year-ago quarter. The current stock performance of DTE Energy shows a 52-week-high of $145.43 and a 52-week-low of $108.22. Moreover, at the end of the last trading period, the closing price was at $119.57.
See all analyst ratings downgrades.
Initiations
- William Blair initiated coverage on The Beauty Health Co SKIN with an Outperform rating. The current stock performance of Beauty Health shows a 52-week-high of $30.17 and a 52-week-low of $11.12. Moreover, at the end of the last trading period, the closing price was at $21.79.
- B. Riley Securities initiated coverage on CompoSecure Inc CMPO with a Buy rating. The price target for CompoSecure is set to $17.00. The stock has a 52-week-high of $10.69 and a 52-week-low of $6.63. At the end of the last trading period, CompoSecure closed at $6.96.
- With a Buy rating, Maxim Group initiated coverage on Quoin Pharmaceuticals Ltd QNRX. The price target seems to have been set at $5.00 for Quoin Pharmaceuticals. In the third quarter, Quoin Pharmaceuticals showed an EPS of $1.40, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $29.80 and a 52-week-low of $1.51. At the end of the last trading period, Quoin Pharmaceuticals closed at $1.74.
- With a Buy rating, Maxim Group initiated coverage on NeuroSense Therapeutics Ltd NRSN. The price target seems to have been set at $7.00 for NeuroSense Therapeutics. The stock has a 52-week-high of $4.70 and a 52-week-low of $2.39. At the end of the last trading period, NeuroSense Therapeutics closed at $2.53.
- With an Outperform rating, Wedbush initiated coverage on Planet Labs PBC PL. The price target seems to have been set at $10.00 for Planet Labs. Planet Labs earned $1.38 in the third quarter, compared to $1.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.65 and a 52-week-low of $4.95. Planet Labs closed at $5.26 at the end of the last trading period.
- Credit Suisse initiated coverage on Vicarious Surgical Inc RBOT with an Outperform rating. The price target for Vicarious Surgical is set to $16.00. The stock has a 52-week-high of $15.79 and a 52-week-low of $9.20. At the end of the last trading period, Vicarious Surgical closed at $9.31.
- Credit Suisse initiated coverage on SS&C Technologies Holdings Inc SSNC with an Outperform rating. The price target for SS&C Technologies Hldgs is set to $105.00. In the third quarter, SS&C Technologies Hldgs showed an EPS of $1.32, compared to $1.10 from the year-ago quarter. The stock has a 52-week-high of $83.80 and a 52-week-low of $62.51. At the end of the last trading period, SS&C Technologies Hldgs closed at $82.95.
- With a Positive rating, Susquehanna initiated coverage on AerCap Holdings NV AER. The price target seems to have been set at $80.00 for AerCap Holdings. For the third quarter, AerCap Holdings had an EPS of $4.04, compared to year-ago quarter EPS of $1.24. The current stock performance of AerCap Holdings shows a 52-week-high of $71.38 and a 52-week-low of $37.29. Moreover, at the end of the last trading period, the closing price was at $66.78.
- Piper Sandler initiated coverage on Immuneering Corp IMRX with an Overweight rating. The price target for Immuneering is set to $41.00. For the third quarter, Immuneering had an EPS of $0.47, compared to year-ago quarter EPS of $0.89. The current stock performance of Immuneering shows a 52-week-high of $33.99 and a 52-week-low of $13.93. Moreover, at the end of the last trading period, the closing price was at $14.14.
- Piper Sandler initiated coverage on Intellia Therapeutics Inc NTLA with an Overweight rating. The price target for Intellia Therapeutics is set to $171.00. In the third quarter, Intellia Therapeutics showed an EPS of $0.97, compared to $0.47 from the year-ago quarter. The current stock performance of Intellia Therapeutics shows a 52-week-high of $202.73 and a 52-week-low of $43.86. Moreover, at the end of the last trading period, the closing price was at $104.57.
- BTIG initiated coverage on Ginkgo Bioworks Holdings Inc DNA with a Buy rating. The price target for Ginkgo Bioworks Holdings is set to $12.00. At the moment, the stock has a 52-week-high of $15.86 and a 52-week-low of $6.60. Ginkgo Bioworks Holdings closed at $6.90 at the end of the last trading period.
- With an Overweight rating, Stephens & Co. initiated coverage on OncoCyte Corp OCX. The price target seems to have been set at $3.10 for OncoCyte. For the third quarter, OncoCyte had an EPS of $0.10, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $6.57 and a 52-week-low of $1.94. At the end of the last trading period, OncoCyte closed at $2.06.
- Stephens & Co. initiated coverage on Veracyte Inc VCYT with an Overweight rating. The price target for Veracyte is set to $52.00. In the third quarter, Veracyte showed an EPS of $0.20, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $86.03 and a 52-week-low of $32.87. At the end of the last trading period, Veracyte closed at $35.12.
- For DermTech Inc DMTK, Stephens & Co. initiated coverage, by setting the current rating at Overweight. In the third quarter, DermTech showed an EPS of $0.68, compared to $0.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $84.49 and a 52-week-low of $14.67. DermTech closed at $15.11 at the end of the last trading period.
- With an Overweight rating, Stephens & Co. initiated coverage on Castle Biosciences Inc CSTL. The price target seems to have been set at $59.00 for Castle Biosciences. Castle Biosciences earned $0.47 in the third quarter, compared to $0.23 in the year-ago quarter. The stock has a 52-week-high of $107.69 and a 52-week-low of $37.99. At the end of the last trading period, Castle Biosciences closed at $39.63.
- With an Outperform rating, Keefe, Bruyette & Woods initiated coverage on Bill.com Holdings Inc BILL. The price target seems to have been set at $300.00 for Bill.com Holdings. For the first quarter, Bill.com Holdings had an EPS of $0.15, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $348.50 and a 52-week-low of $109.64. At the end of the last trading period, Bill.com Holdings closed at $202.90.
- With a Buy rating, Goldman Sachs initiated coverage on Upwork Inc UPWK. The price target seems to have been set at $46.00 for Upwork. For the third quarter, Upwork had an EPS of $0.04, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $64.49 and a 52-week-low of $28.34. Upwork closed at $29.39 at the end of the last trading period.
- With a Buy rating, Goldman Sachs initiated coverage on ACV Auctions Inc ACVA. The price target seems to have been set at $26.00 for ACV Auctions. The current stock performance of ACV Auctions shows a 52-week-high of $37.77 and a 52-week-low of $16.15. Moreover, at the end of the last trading period, the closing price was at $17.53.
- With a Neutral rating, Goldman Sachs initiated coverage on Vacasa Inc VCSA. The price target seems to have been set at $10.00 for Vacasa. At the moment, the stock has a 52-week-high of $11.00 and a 52-week-low of $6.90. Vacasa closed at $8.27 at the end of the last trading period.
- Goldman Sachs initiated coverage on Nerdy Inc NRDY with a Buy rating. The price target for Nerdy is set to $8.00. The current stock performance of Nerdy shows a 52-week-high of $13.49 and a 52-week-low of $3.83. Moreover, at the end of the last trading period, the closing price was at $3.98.
- With a Neutral rating, Goldman Sachs initiated coverage on Enjoy Technology Inc ENJY. The price target seems to have been set at $6.00 for Enjoy Technology. The current stock performance of Enjoy Technology shows a 52-week-high of $13.11 and a 52-week-low of $3.65. Moreover, at the end of the last trading period, the closing price was at $4.00.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in